Publications by authors named "E Toschi"
Background: Young adults (YA) with type 1 diabetes mellitus (T1D) are at high risk of worsening glycated haemoglobin (HbA1c) with fewer follow-up visits. We examined the association of demographic and diabetes characteristics with care utilization, including in-person and telehealth visits, pre- (1 April 2019 to 15 March 2020) and during the COVID-19 pandemic (30 March 2020 to 15 March 2021) for YA (ages: 18-30) with T1D, comparing those seen in paediatric versus adult diabetes clinics at a single diabetes centre.
Methods: Data were obtained from the electronic health record for YA with a pre-pandemic HbA1c.
Aims: To evaluate the use of hybrid (telehealth and in-person) care on visitation and glycaemia in older adults with type 1 diabetes (T1D).
Methods: In this retrospective study, we examined clinical characteristics, number of visits (telehealth and in-person) and continuous glucose monitoring (CGM) metrics for older adults (≥65 years) with T1D from electronic health records during the pre-COVID-19 pandemic (March 1, 2019-March 1, 2020; in-person) and pandemic (September 1, 2020-August 31, 2021; hybrid) periods. Main outcomes were the number of visits and changes in glycaemic control (HbA1c), and in a sub-group of older adults using CGM, changes in CGM metrics between in-person and hybrid care.
Article Synopsis
- Young women with type 1 diabetes are at increased risk for eating disorders, prompting a study of a new prevention program called the Diabetes Body Project.
- In a randomized trial, women aged 14-35 were divided into groups for the program or an educational control, with evaluations done shortly after.
- Results showed the Diabetes Body Project led to significant improvements in eating disorder symptoms, diabetes distress, quality of life, and other related issues compared to the control group, suggesting it could be widely implemented.
Article Synopsis
- Continuous glucose monitoring (CGM) combined with geriatric-focused treatment can effectively reduce hypoglycemia in older adults with type 1 diabetes without harming overall blood sugar control.
- A study involving older adults with a history of hypoglycemia found significant reductions in time spent with low blood sugar in those using CGM and tailored treatment versus traditional care.
- The intervention proved cost-effective, with a cost of $71,623 per quality-adjusted life-year, suggesting it offers good value for enhancing the health of this patient group.